Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.

You are here:Home-ADCs and PROTACs-ADC Cytotoxin-Daun02
Daun02

Chemical Structure : Daun02

CAS No.: 290304-24-4

Daun02 (Daun 02, Daun-02)

Catalog No.: PC-43365Not For Human Use, Lab Use Only.

Daun02 is a prodrug that is converted by β-galactosidase to Daunorubicin and topoisomerase inhibitor, specifically attenuates cocaine-induced locomotor activity , also attenuates cocaine-induced β-galactosidase expression.

Packing Price Stock Quantity
5 mg $198 In stock
10 mg $298 In stock
25 mg $498 In stock
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

Welcome credit card payment!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

Daun02 is a prodrug that is converted by β-galactosidase to Daunorubicin and topoisomerase inhibitor, specifically attenuates cocaine-induced locomotor activity , also attenuates cocaine-induced β-galactosidase expression.
Daunorubicin, the active product of Daun02 metabolism by β-galactosidase, decreases the activity of MSNs in rat brain slices and that Daun02 strongly decreases the excitability of rat MSN primary cultures expressing β-galactosidase upon D1 dopamine receptor stimulation.
Daun02 selectively inactivate only those neurons activated by cocaine in an environment repeatedly paired with drug injections.

Physicochemical Properties

M.Wt 884.7895
Formula C41H44N2O20
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

(1R,2R,6S,18R,20S)-3-nitro-4-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-2-yloxy)benzyl (2S,3S,4S,6R)-6-(3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yloxy)-3-hydroxy-2-methyl-tetrahydro-2H

References

1. Koya E, et al. Nat Neurosci. 2009 Aug;12(8):1069-73.

2. Farquhar D, et al. Cancer Chemother Pharmacol. 2002 Jul;50(1):65-70.

3. Koya E, et al. Curr Protoc Neurosci. 2016 Jul 1;76:8.36.1-8.36.17.

4. Cruz FC, et al. J Neurosci. 2014 May 28;34(22):7437-46.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: